Can higher selenium exposure raise fasting glucose and type 2 diabetes risk?

Research into the relationship between selenium and metabolic health has shifted significantly as large-scale data reveals that while selenium is an essential micronutrient, excess levels may interfere with glucose regulation. This association is particularly evident in populations where selenium intake is already adequate or high.

Clinical evidence for glucose and diabetes risk

Extensive observational data and meta-analyses consistently link higher selenium levels to increased fasting plasma glucose (FPG) and type 2 diabetes (T2D) risk.

• Diabetes Prevalence: A meta-analysis of observational studies involving 13,460 participants found a non-linear relationship, with an odds ratio (OR) for T2D of 1.06 per 10 µg/L increase in blood selenium. Individuals in the highest quintile of serum selenium (>122 µg/L) had a 50% higher prevalence of diabetes compared to those in the lowest quintile (<105 µg/L).
• Fasting Glucose: In large-scale studies, each 10 µg/L increase in blood selenium has been associated with a 0.08 mmol/L increase in fasting glucose.
• Risk Escalation: Longitudinal data from the Nutritional Prevention of Cancer (NPC) trial showed that participants in the highest tertile of baseline plasma selenium (>121.6 ng/mL) faced a significantly increased risk of T2D when supplemented with 200 µg/day (HR 1.55; 95% CI, 1.03-2.33).
• Population Variance: This risk appears most pronounced in selenium-replete regions, such as the United States. In contrast, in selenium-deficient regions, the relationship may be neutral or even protective, suggesting a U-shaped or threshold-dependent effect where risk only increases once a state of "repletion" is reached.

Mechanistic explanations

The diabetogenic effect of high selenium is primarily mediated through the overexpression of specific selenoproteins that interact with insulin signaling.

• Insulin Signaling Interference: While glutathione peroxidase 1 (GPx1) is a vital antioxidant, its overexpression at high selenium levels can paradoxically "over-clear" reactive oxygen species (ROS). Because controlled levels of ROS are necessary for the activation of the insulin receptor, this excessive antioxidant activity can impair insulin signaling and promote resistance.
• Hepatic Glucose Production: High selenium levels may upregulate phosphoenolpyruvate carboxykinase (PEPCK), a key enzyme in gluconeogenesis, leading to increased glucose production by the liver.
• Beta-Cell Function: Excessive selenium may impair pancreatic beta-cell function through oxidative stress or protein misfolding when selenium is incorrectly incorporated into proteins at high concentrations.

Bottom line

Higher selenium exposure is strongly associated with elevated fasting glucose and an increased risk of type 2 diabetes in populations with already adequate selenium status. This effect is driven by the overexpression of selenoproteins that disrupt insulin signaling and increase hepatic glucose production, highlighting the importance of avoiding supranutritional selenium intake in the absence of deficiency.